Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis
- 1 November 1990
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 163 (5) , 1679-1684
- https://doi.org/10.1016/0002-9378(90)90650-v
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Studies on GnRH Agonist Suppression of Estrogen Production in Patients with Endometriosis.Endocrinologia Japonica, 1989
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Analysis of danazol in serum using high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitroAmerican Journal of Obstetrics and Gynecology, 1986
- Clomiphene citrate induces pituitary GnRH receptors in ovariectomized rats: its possible role in induction of ovulationActa Endocrinologica, 1986
- The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the ratActa Endocrinologica, 1984
- STIMULATION OF LH FRAGMENTS WITH REDUCED BIOACTIVITY FOLLOWING GnRH AGONIST ADMINISTRATION IN WOMENJournal of Clinical Endocrinology & Metabolism, 1984
- INHIBITION OF HUMAN GRANULOSA CELL PROGESTERONE SECRETION BY A GONADOTROPIN-RELEASING HORMONE AGONISTJournal of Clinical Endocrinology & Metabolism, 1982
- Danazol has progestin-like actions on the human endometriumActa Endocrinologica, 1982
- Danazol: Endocrine pharmacology and therapeutic applicationsAmerican Journal of Obstetrics and Gynecology, 1981